Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 ng » 100 mg (Expand Search), 100 nm (Expand Search), 100 ns (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 ng » 100 mg (Expand Search), 100 nm (Expand Search), 100 ns (Expand Search)
-
261
Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States...
Published 2019“…Finally, the Φ<sub>PL</sub> of TAPC:TX-TerPy (7:1) and TCTA:TX-TerPy (7:1) are 65.2 and 69.6%. When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
-
262
Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States...
Published 2019“…Finally, the Φ<sub>PL</sub> of TAPC:TX-TerPy (7:1) and TCTA:TX-TerPy (7:1) are 65.2 and 69.6%. When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
-
263
-
264
-
265
-
266
-
267
-
268
-
269
-
270
-
271
-
272
-
273
-
274
-
275
-
276
-
277
-
278
-
279
-
280
Characterization of cisplatin resistance phenotype in A2780 and A2780cp cells.
Published 2025Subjects: